Publication | Closed Access

Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines

Alzheimer's DiseaseAcetylcholinesterase InhibitorMedicineDementiaPharmacologyAlzheimer PatientsVascular DementiaAnti-inflammatory CytokinesNeurochemical BiomarkersNeuroscienceNeurologyNeurodegenerationAging-associated DiseaseNeuroimmunologyTreatmentNeuroinflammation